Digicann Ventures Inc (AGFAF)
0.011
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Digicann Ventures Max Drawdown (5Y): 100.00% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 100.00% |
March 31, 2024 | 100.00% |
February 29, 2024 | 100.00% |
January 31, 2024 | 100.00% |
December 31, 2023 | 100.00% |
November 30, 2023 | 100.00% |
October 31, 2023 | 100.00% |
September 30, 2023 | 100.00% |
August 31, 2023 | 100.00% |
July 31, 2023 | 100.00% |
June 30, 2023 | 100.00% |
May 31, 2023 | 100.00% |
April 30, 2023 | 99.99% |
March 31, 2023 | 99.99% |
February 28, 2023 | 99.99% |
January 31, 2023 | 99.99% |
December 31, 2022 | 99.99% |
November 30, 2022 | 99.99% |
October 31, 2022 | 99.99% |
September 30, 2022 | 99.99% |
August 31, 2022 | 99.99% |
July 31, 2022 | 99.98% |
June 30, 2022 | 99.97% |
May 31, 2022 | 99.97% |
April 30, 2022 | 99.92% |
Date | Value |
---|---|
March 31, 2022 | 99.68% |
February 28, 2022 | 99.61% |
January 31, 2022 | 99.60% |
December 31, 2021 | 99.56% |
November 30, 2021 | 99.43% |
October 31, 2021 | 99.18% |
September 30, 2021 | 99.14% |
August 31, 2021 | 98.32% |
July 31, 2021 | 97.50% |
June 30, 2021 | 97.50% |
May 31, 2021 | 97.50% |
April 30, 2021 | 97.50% |
March 31, 2021 | 97.50% |
February 28, 2021 | 97.50% |
January 31, 2021 | 97.50% |
December 31, 2020 | 97.50% |
November 30, 2020 | 97.50% |
October 31, 2020 | 97.50% |
September 30, 2020 | 97.48% |
August 31, 2020 | 95.80% |
July 31, 2020 | 95.80% |
June 30, 2020 | 95.80% |
May 31, 2020 | 95.80% |
April 30, 2020 | 95.80% |
March 31, 2020 | 95.80% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
93.68%
Minimum
May 2019
100.00%
Maximum
Oct 2023
97.97%
Average
99.31%
Median
Max Drawdown (5Y) Benchmarks
Acasti Pharma Inc | 98.73% |
Aurinia Pharmaceuticals Inc | 87.58% |
Edesa Biotech Inc | 99.58% |
Lexaria Bioscience Corp | 98.90% |
Xenon Pharmaceuticals Inc | 64.74% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -112.13 |
Beta (5Y) | 1.761 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 114.7% |
Historical Sharpe Ratio (5Y) | -0.8066 |
Historical Sortino (5Y) | -1.383 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 59.43% |